Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
一项随机临床试验比较了拟上市的雷珠单抗生物类似药与参考雷珠单抗产品治疗新生血管性年龄相关性黄斑变性的疗效和安全性。
期刊:Jama Ophthalmology
影响因子:9.2
doi:10.1001/jamaophthalmol.2020.5053
Woo, Se Joon; Veith, Miroslav; Hamouz, Jan; Ernest, Jan; Zalewski, Dominik; Studnicka, Jan; Vajas, Attila; Papp, Andras; Gabor, Vogt; Luu, James; Matuskova, Veronika; Yoon, Young Hee; Pregun, Tamás; Kim, Taehyung; Shin, Donghoon; Bressler, Neil M
